KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Repligen (RGEN) EBT (2016 - 2025)

Repligen (RGEN) has disclosed EBT for 16 consecutive years, with -$66.8 million as the latest value for Q4 2025.

  • Quarterly EBT fell 231.68% to -$66.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$23.5 million through Dec 2025, down 137.75% year-over-year, with the annual reading at -$23.5 million for FY2025, 137.75% down from the prior year.
  • EBT for Q4 2025 was -$66.8 million at Repligen, down from $17.1 million in the prior quarter.
  • The five-year high for EBT was $59.8 million in Q2 2022, with the low at -$100.5 million in Q4 2022.
  • Average EBT over 5 years is $13.4 million, with a median of $18.4 million recorded in 2023.
  • Peak annual rise in EBT hit 1589.3% in 2025, while the deepest fall reached 231.68% in 2025.
  • Over 5 years, EBT stood at -$36.7 million in 2021, then crashed by 173.65% to -$100.5 million in 2022, then soared by 126.63% to $26.8 million in 2023, then skyrocketed by 89.56% to $50.7 million in 2024, then tumbled by 231.68% to -$66.8 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at -$66.8 million, $17.1 million, and $18.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.